Progrès dans l'étude du mécanisme d'action de l'astragaloside via la régulation de la voie moléculaire PI3K/Akt dans la prévention et le traitement des complications du diabète

  • role: First author第一作者
  • Affiliation:

    Anhui University of Chinese Medicine,Hefei 230012,China

  • Email:hkx835031518@163.com
  • Introduction:胡可心,在读硕士,住院医师,从事中医药防治内分泌疾病研究,E-mail:hkx835031518@163.com
HU Kexin1,  
  • Affiliation:

    Anhui University of Chinese Medicine,Hefei 230012,China

ZHU Jinru1,  
  • Affiliation:

    Anhui University of Chinese Medicine,Hefei 230012,China

WU Qing1,  
  • Affiliation:

    Anhui University of Chinese Medicine,Hefei 230012,China

WANG Shengmao1,  
  • Affiliation:

    Anhui University of Chinese Medicine,Hefei 230012,China

WANG Mengfan1,  
  • Affiliation:

    Anhui University of Chinese Medicine,Hefei 230012,China

QIAN Ai1,  
  • role: Corresponding author通信作者
  • Affiliation:

    The First Affiliated Hospital of Anhui University of Chinese Medicine,Hefei 230031,China

    Key Laboratory of Xin'an Medical Education Department,Anhui University of Chinese Medicine, Hefei 230038,China

  • Email:fangzhaohui1111@163.com
  • Introduction:方朝晖,博士,教授,主任医师,博士生导师,从事中医药防治内分泌疾病研究,E-mail:fangzhaohui1111@163.com
FANG Zhaohui23*

résumé

Le diabète sucré (DM) est une maladie métabolique résultant d'une insuffisance absolue ou relative de la sécrétion d'insuline et d'une diminution de la sensibilité des cellules périphériques à l'insuline, affectant gravement la santé de l'humanité. Les complications chroniques tardives peuvent provoquer la défaillance ou la perte de fonctions de plusieurs organes tels que les yeux, le cœur, le foie, les reins, les nerfs et les pieds, constituant la cause principale de décès chez les patients diabétiques. La médecine moderne a réalisé certains progrès dans le traitement des complications, mais elle fait encore face à des problèmes de coûts élevés et d'effets indésirables significatifs des médicaments. La recherche de médicaments peu coûteux et efficaces est donc une priorité. L'astragale est une perle brillante dans le trésor de la médecine traditionnelle chinoise. De nombreuses études ont montré que son composant principal, l’astragaloside, possède des activités anti-inflammatoires, antioxydantes, antivirales, améliore les fonctions cardiaques et cérébrales, améliore la conduction nerveuse et protège le myocarde. Par ailleurs, la voie de signalisation phosphatidylinositol 3-kinase/protéine kinase B (PI3K/Akt) est une voie importante régulant plusieurs mécanismes tels que le stress oxydatif, la réponse inflammatoire, l'apoptose et l'autophagie. Plusieurs expériences ont montré son importance dans diverses complications du diabète, suscitant des recherches étendues sur leur combinaison. Cet article passe en revue les études démontrant que l'astragaloside réduit la cytotoxicité des cellules pancréatiques chez les patients diabétiques en régulant la voie PI3K/Akt, protège les fonctions cardiaques essentielles, inhibe les lésions cellulaires de la rétine, améliore le dysfonctionnement neurologique cérébral, diminue les dommages chroniques aux reins et au foie, ainsi qu’atténue les lésions toxiques des nerfs et des vaisseaux des membres inférieurs, fournissant une référence pour l’application clinique de l’astragale et de son monomère astragaloside dans le diabète et ses complications.

mots-clés

Astragaloside; voie de signalisation phosphatidylinositol 3-kinase/protéine kinase B (PI3K/Akt); complications diabétiques; progrès en pharmacologie

References

  1. 1.
    ZHAO X K,WANG X Q,JIANG H G,et al.Research status of effective active components of Astragalus in preventing and treating myocardial fibrosis[J].Chin J Clin Pharmacol,2023,39(4):593-597.
  2. 2.
    FAN L H,WANG Z G,YANG X,et al.Study on interventional effect of Gelian Tiaotang pill on renal fibrosis in type 2 diabetes db/db mice through NLRP3/Caspase-1/GSDMD pathway[J].Chin J Exp Tradit Med Form,2025,31(6):136-145.
  3. 3.
    WANG X Y,LIU H F,LIU X Z.Research progress on the mechanism of traditional Chinese medicine promoting Angiogenesis after ischemic stroke based on the PI3K/Akt signaling pathway[J].Chin J Exp Tradit Med Form,2025,31(7):265-274.
  4. 4.
    BELLI C,REPETTO M,ANAND S,et al.The emerging role of PI3K inhibitors for solid tumour treatment and beyond[J].Br J Cancer,2023,128 (12):2150-2162.
  5. 5.
    LEANDRO-GARCÍA L J,LANDA I.Mechanistic insights of thyroid cancer progression[J].Endocrinology,2023,164 (9):bqad118.
  6. 6.
    WANG M,ZHANG Y L,ZOU J,et al.To investigate the effect of electroacupuncture "Jiaji point" on autophagy and apoptosis of nucleus pulposus cells in degenerative intervertebral disc based on PI3K/Akt/mTOR pathway[J/OL].Acupunct Res,2024,.
  7. 7.
    XU F,NA L,LI Y,et al.Roles of the PI3K/Akt/mTOR signalling pathways in neurodegenerative diseases and tumours[J].Cell Biosci,2020,10(1):54.
  8. 8.
    CASTRO-CRUZ A,ECHEVERRÍA O M,SÁNCHEZ-SÁNCHEZ L,et al.Dissection of the autophagic route in oocytes from atretic follicles[J].Biol Cell,2023,115 (3):e2200046.
  9. 9.
    CHEN J M,LIN Z L,CHEN F S,et al.Effects of PPⅥ on apoptosis and autophagy of esophageal cancer cells ECA-109 by regulating PI3K/Akt/mTOR pathway[J].Heilongjiang Med J,2024,37(4):767-771.
  10. 10.
    ZHU Y,XU W J,ZHANG Y Y,et al.Quercetin regulates proliferation,inflammation,and oxidative stress in psoriatic keratinocytes via the NF-κB signaling pathway[J].J Clin Pathol Res,2024,44(5):647-655.
  11. 11.
    ZHENG X,WU X,WEN Q,et al.Eriodictyol alleviated LPS/D-GalN-induced acute liver injury by inhibiting oxidative stress and cell apoptosis via PI3K/Akt signaling pathway[J].Nutrients,2023,15 (20):4349.
  12. 12.
    DONG M,REN M,LI C,et al.Analysis of metabolic alterations related to pathogenic process of diabetic encephalopathy rats[J].Front Cell Neurosci,2018,12:527.
  13. 13.
    YE X,SHEN T,HU J,et al.Purinergic 2X7 receptor/NLRP3 pathway triggers neuronal apoptosis after ischemic stroke in the mouse[J].Exp Neurol,2017,292:46-55.
  14. 14.
    CUI W.Study on the mechanism of Buyang Huanwu decoction on diabetic encephalopathy through PI3K/Akt pathway[D].Changchun:Changchun University of Chinese Medicine,2022.
  15. 15.
    WANG Z,LUO Z,TAN Y,et al.Astragaloside Ⅳ alleviates heatstroke brain injury and neuroinflammation in male mice by regulating microglial polarization via the PI3K/Akt signaling pathway[J].Biomed Pharmacother,2024,180:117545.
  16. 16.
    CHENG F,ZHANG J,YANG P,et al.Exploring the neuroprotection of the combination of astragaloside A,chlorogenic acid and scutellarin in treating chronic cerebral ischemia via network analysis and experimental validation[J].Heliyon,2024,10 (8):e29162.
  17. 17.
    TANG X,LI X,ZHANG D,et al.Astragaloside-Ⅳ alleviates high glucose-induced ferroptosis in retinal pigment epithelial cells by disrupting the expression of miR-138-5p/Sirt1/Nrf2[J].Bioengineered,2022,13 (4):8240-8254.
  18. 18.
    WANG T,ZHANG Z,SONG C,et al.Astragaloside Ⅳ protects retinal pigment epithelial cells from apoptosis by upregulating miR‑128 expression in diabetic rats[J].Int J Mol Med,2020,46 (1):340-350.
  19. 19.
    FANG Y W.The study of Mingmu Xiaomeng tablet regulates autophagythrough Pl3K/Akt/mTOR pathway in diabetic retinopathy[D].Guangzhou:Guangzhou University of Traditional Chinese Medicine,2020
  20. 20.
    YU N X,LI G Q,LI B,et al.Mechanism of Astragaloside Ⅳ in treating diabetic retinopathy based on network pharmacology and molecular docking[J].Chin J Exp Tradit Med Form,2022,28(13):209-216.
  21. 21.
    GAO Y K,LIANG Y L,ZHU X D,et al.Advances in the research of pathogenesis and Chinese medicine role in diabetic cardiomyopathy using omics technology[J].Chin J Integr Tradit West Med,1-5[2004-09-10].
  22. 22.
    WANG L Y,LI C,MA M Y,et al.Effects of Astragaloside Ⅳ on cardiac hypertrophy in rats with chronic heart failure based on PI3K/Akt/GSK-3β signaling pathway[J].Chin J Clinl Pharmacol,2024,40(1):57-61.
  23. 23.
    ZHANG B,MA Q,MA F Z,et al.Astragaloside Ⅳ's therapeutic effect on myocardial infarction via affecting autophagy and the mechanism study[J].J Sichuan Univ(Med Sci),2021,52(2):222-228.
  24. 24.
    CHENG S,ZHANG X,FENG Q,et al.Astragaloside Ⅳ exerts angiogenesis and cardioprotection after myocardial infarction via regulating PTEN/PI3K/Akt signaling pathway[J].Life Sci,2019,227:82-93.
  25. 25.
    WU Y,ZHANG H,CHEN Y H,et al.To investigate the protective mechanisms of astragaloside Ⅳ on cardiac function in diabetic cardiomyopathy rats based on the PI3K/Akt/eNOS signaling pathway[J].Lishizhen Med Mater Med Res,2023,34(10):2329-2332.
  26. 26.
    SAKAI S,YAMAMOTO T,TAKABATAKE Y,et al.Proximal tubule autophagy differs in type 1 and 2 diabetes[J].J Am Soc Nephrol,2019,30 (6):929-945.
  27. 27.
    YANG F,QU Q,ZHAO C,et al.Paecilomyces cicadae-fermented Radix astragali activates podocyte autophagy by attenuating PI3K/Akt/mTOR pathways to protect against diabetic nephropathy in mice[J].Biomed Pharmacother,2020,129:110479.
  28. 28.
    LIU C Q,HUANG S J,JIANG D.Effect of astragaloside combined with losartan on PI3K/Akt/NF-κB pathway in diabetic rat kidney[J].Cent South Pharm,2019,17 (10):1626-1630.
  29. 29.
    SU X,GUO H,ZHOU Y,et al.Astragaloside Ⅳ attenuates high glucose-induced NF-κB-mediated inflammation through activation of PI3K/Akt-ERK-dependent Nrf2/ARE signaling pathway in glomerular mesangial cells[J].Phytother Res,2023,37 (9):4133-4148.
  30. 30.
    SUN L,YANG Z,ZHAO W,et al.Integrated lipidomics,transcriptomics and network pharmacology analysis to reveal the mechanisms of Danggui Buxue decoction in the treatment of diabetic nephropathy in type 2 diabetes mellitus[J].J Ethnopharmacol,2022,283:114699.
  31. 31.
    LV J,SU M,WANG Y,et al.Yunvjian decoction mitigates hyperglycemia in rats induced by a high-fat diet and streptozotocin via reducing oxidative stress in pancreatic beta cells[J].J Ethnopharmacol,2024,327:118045.
  32. 32.
    GONG P,XIAO X,WANG S,et al.Hypoglycemic effect of astragaloside Ⅳ via modulating gut microbiota and regulating AMPK/SIRT1 and PI3K/Akt pathway[J].J Ethnopharmacol,2021,281:114558.
  33. 33.
    LIN Y,XU Y,ZHENG X,et al.Astragaloside Ⅳ ameliorates streptozotocin induced pancreatic β-cell apoptosis and dysfunction through SIRT1/P53 and Akt/GSK3β/Nrf2 signaling pathways[J].Diabetes Metab Syndr Obes,2022,15:131-140.
  34. 34.
    QING J,ZHOU H,CHEN L,et al.Effect and mechanism of carvacrol on liver injury in type 2 diabetes mellitus[J].Chin Arch Tradit Chin Med,2024,42 (02):131-135+280-284.
  35. 35.
    SONG L,LI Y,XU M.Exogenous nucleotides ameliorate insulin resistance induced by palmitic acid in HepG2 cells through the IRS-1/Akt/FOXO1 pathways[J].Nutrients,2024,16 (12):1801.
  36. 36.
    XU Y,HUANG C D,LI Z Q,et al.Protective effects of astragaloside Ⅳ on liver injury in diabetic rats and its mechanism[J].Acta Univ Med Anhui,2017,52 (12):1823-1829.
  37. 37.
    ZHENG W,YANG S S,LIN Y,et al.Impact of pumpkin polysaccharides on hypoxia/reoxygenation-induced myocardial cell injury by regulating Nrf2/γ-GCS pathway[J].Chin J Immunol,2024,40(9):1871-1875.
  38. 38.
    JI T J.Molecular mechanism of astragaloside Ⅳ regulating PI3K/Akt pathway to improve abnormal liver glucose metabolism in type 2 diabetic rats[D].Hefei:Anhui Medical University,2020.
  39. 39.
    ZHU X L,LIAO W Q,ZHANG C,et al.Pathogenesis and treatment of diabetic foot ulcer[J].Chin J Dermatovenereol,2023,37(4):367-372.
  40. 40.
    JI X R,BAI C P,LI X L,et al.Discussion on the mechanism of Chinese medicinals pair Huangqi-Guizhi on diabetic foot based on network pharmacology[J].Clin J Chin Med,2021,13(28):33-38.
  41. 41.
    ABD EL-KHALIK S R ,HAFEZ Y M,ELKHOLY R A.The role of circulating soluble fms-like tyrosine kinase-1 in patients with diabetic foot ulcer:A possible mechanism of pathogenesis via a novel link between oxidative stress,inflammation and angiogenesis[J].Microvasc Res,2020,130:103987.
  42. 42.
    ZHANG J,ZHANG G S,HUANG X,et al.Effects of beraprost sodium tablets combined with Danggui Huangqi Decoction(当归黄芪汤)on wound healing,angiogenesis and oxidative stress in diabetic foot ulcer patients[J].Chin Arch Tradit Chin Med,2024,42(7):202-205.
  43. 43.
    SHAO S,LU M L,WANG H X,et al.Protective effect of astragaloside Ⅳ on oxidative injury of MC3T3-E1 cells induced by liposolysaccharideand its mechanism[J].J Jilin Univ(Med Edi),2023,49(1):1-7.
  44. 44.
    LAI P K,CHAN J Y,CHENG L,et al.Isolation of anti-inflammatory fractions and compounds from the root of Astragalus membranaceus[J].Phytother Res,2013,27 (4):581-587.
  45. 45.
    LI X,WANG Y,TU S W,et al.Research progress on the role and mechanism of mitochondrial apoptosis in diabetic peripheral neuropathy[J].Chin Med Mod Dist Edu China,2021,19(4):200-204.
  46. 46.
    YIN Y,QU H,YANG Q,et al.Astragaloside Ⅳ alleviates Schwann cell injury in diabetic peripheral neuropathy by regulating microRNA-155-mediated autophagy[J].Phytomedicine,2021,92:153749.
  47. 47.
    WU Y T.Clinical effect of danzhi jiangtangcapsule on type 2 diabetic macroangiopathyand its effect on ASK1-JNK signal pathway inaorta of sd rat[D].Hefei:Anhui University of Traditional Chinese Medicine,2022.
  48. 48.
    PENG M J,TANG R,LUO K,et al.Pharmacological research progress of Huangqi Danggui under different combinations[J].Sci Technol Vis,2017,(36):17,48.
  49. 49.
    WANG N,ZHANG X,MA Z,et al.Combination of tanshinone ⅡA and astragaloside Ⅳ attenuate atherosclerotic plaque vulnerability in ApoE-/- mice by activating PI3K/Akt signaling and suppressing TRL4/NF-κB signaling[J].Biomed Pharmacother,2020,123:109729.
  50. 50.
    LI S,SUN Y,HUANG J,et al.Anti-tumor effects and mechanisms of Astragalus membranaceus (AM) and its specific immunopotentiation:Status and prospect[J].J Ethnopharmacol,2020,258:112797.
  51. 51.
    LUO Y Y,MENG M H,LI Y,et al.Copper influences the occurrence and development of diabetic complications[J].Chin J Tissue Engin Res,2025,29(17):3641-3649.
  52. 52.
    XU R S,YANG X M,XU Y F,et al.Therapeutic effect of Astragaloside Ⅳ based on phosphatidylinositol 3-kinase/protein kinase B(PI3K/Akt) signaling pathway[J].Chin J Clin Pharmacol,2022,38(8):855-858,873.

Lire l'article complet

The above content is generated by Large Model Translation. The translated content is for reference only. We do not assume any commercial or legal responsibilty for any consequences arising from the use of our website